Details for New Drug Application (NDA): 210748
✉ Email this page to a colleague
The generic ingredient in AZACITIDINE is azacitidine. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the azacitidine profile page.
Summary for 210748
Tradename: | AZACITIDINE |
Applicant: | Lupin Ltd |
Ingredient: | azacitidine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 210748
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS, SUBCUTANEOUS | Strength | 100MG/VIAL | ||||
Approval Date: | Feb 27, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription